BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16012904)

  • 1. Dronedarone (Sanofi-Synthélabo).
    Le Grand B
    IDrugs; 2001 May; 4(5):582-5. PubMed ID: 16012904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SR-90107 (Sanofi-Synthélabo).
    Liu F; Bagley WP; Carroll RC
    IDrugs; 2000 Sep; 3(9):1088-99. PubMed ID: 16049869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SR-121463. Sanofi-Synthélabo.
    Martinez-Castelao A
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1423-7. PubMed ID: 11890358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ximelagatran (AstraZeneca).
    Hopfner R
    Curr Opin Investig Drugs; 2002 Feb; 3(2):246-51. PubMed ID: 12020054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleconaril Sanofi Synthélabo/ViroPharma.
    Billich A
    Curr Opin Investig Drugs; 2000 Nov; 1(3):303-7. PubMed ID: 11249712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exubera. Inhale therapeutic systems.
    Bindra S; Cefalu WT
    Curr Opin Investig Drugs; 2002 May; 3(5):758-62. PubMed ID: 12090549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug evaluation: dronedarone, a novel non-iodinated anti-arrhythmic agent.
    Sablayrolles S; Le Grand B
    Curr Opin Investig Drugs; 2006 Sep; 7(9):842-9. PubMed ID: 17002263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iloperidone (Novartis).
    Hesselink JM
    IDrugs; 2002 Jan; 5(1):84-90. PubMed ID: 12861482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MK-0991 (Merck & Co).
    Groll AH; Walsh TJ
    IDrugs; 1999 Nov; 2(11):1201-12. PubMed ID: 16113992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technology evaluation: adalimumab, Abbott laboratories.
    Lorenz HM
    Curr Opin Mol Ther; 2002 Apr; 4(2):185-90. PubMed ID: 12044041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technology evaluation: Abarelix, Praecis pharmaceuticals.
    Doehn C; Jocham D
    Curr Opin Mol Ther; 2000 Oct; 2(5):579-85. PubMed ID: 11249760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DP-VPA D-Pharm.
    Labiner DM
    Curr Opin Investig Drugs; 2002 Jun; 3(6):921-3. PubMed ID: 12137414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osanetant Sanofi-Synthélabo.
    Kamali F
    Curr Opin Investig Drugs; 2001 Jul; 2(7):950-6. PubMed ID: 11757797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brasofensine NeuroSearch.
    Yu P
    Curr Opin Investig Drugs; 2000 Dec; 1(4):504-7. PubMed ID: 11249705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.
    Dale KM; White CM
    Ann Pharmacother; 2007 Apr; 41(4):599-605. PubMed ID: 17389667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMS-275291. Bristol-Myers Squibb.
    Poulaki V
    Curr Opin Investig Drugs; 2002 Mar; 3(3):500-4. PubMed ID: 12054103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repinotan Bayer.
    Lutsep HL
    Curr Opin Investig Drugs; 2002 Jun; 3(6):924-7. PubMed ID: 12137415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCI-779 Wyeth.
    Elit L
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1249-53. PubMed ID: 12211424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propiram Shire.
    Joshi GP
    IDrugs; 2002 Mar; 5(3):281-5. PubMed ID: 15562339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
    Wegener FT; Ehrlich JR; Hohnloser SH
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.